Beihai Gofar Chuangshan Biological Co., Ltd. logo

Beihai Gofar Chuangshan Biological Co., Ltd. (600538)

Market Closed
11 Aug, 06:57
SSE SSE
¥
5. 13
-0.26
-4.8237%
¥
2.64B Market Cap
- P/E Ratio
0.16% Div Yield
21.52M Volume
- Eps
¥ 5.39
Previous Close
Add Transaction
Day Range
5.1 5.39
Year Range
4.19 7.7
Want to track 600538 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

600538 closed today lower at ¥5.13, a decrease of -4.8237% from yesterday's close, completing a monthly decrease of -16.1765% or -¥0.99. Over the past 12 months, 600538 stock lost -16.1765%.
600538 is not paying dividends to its shareholders.
The last earnings report, released on May 16, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Beihai Gofar Chuangshan Biological Co., Ltd. has completed 2 stock splits, with the recent split occurring on Jun 07, 2006.
The company's stock is traded on one exchange.

600538 Chart

People also search for

Shenzhen YHLO Biotech Co., Ltd.
¥ 9.45
-1.0471%
Shinva Medical Instrument Co., Ltd.
¥ 12.68
-1.2461%
Inventisbio Co., Ltd.
¥ 20.96
+2.5942%
Vcanbio Cell & Gene Engineering Co., Ltd.
¥ 19.89
-0.3008%
Ningbo Yunsheng (Group) Co., Ltd.
¥ 12.3
-1.9139%

Beihai Gofar Chuangshan Biological Co., Ltd. (600538) FAQ

What is the stock price today?

The current price is ¥5.13.

On which exchange is it traded?

Beihai Gofar Chuangshan Biological Co., Ltd. is listed on SSE.

What is its stock symbol?

The ticker symbol is 600538.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.16%.

What is its market cap?

As of today, the market cap is 2.64B.

Has Beihai Gofar Chuangshan Biological Co., Ltd. ever had a stock split?

Beihai Gofar Chuangshan Biological Co., Ltd. had 2 splits and the recent split was on Jun 07, 2006.

Beihai Gofar Chuangshan Biological Co., Ltd. Profile

Biotechnology Industry
Healthcare Sector
Dr. Bin Pan Li CEO
SSE Exchange
CNE000001DD2 ISIN
CN Country
463 Employees
5 Jan 2006 Last Dividend
7 Jun 2006 Last Split
27 Dec 2002 IPO Date

Overview

Beihai Gofar Chuanshan Biological Co., Ltd., previously known as Beihai Gofar Marine Biological Industry Co., Ltd., is a prominent player in the Chinese pharmaceutical industry, specializing in the production and distribution of pharmaceutical products. Recognized for its remarkable Haibao brand, the company has carved a niche in the market since its establishment in 1993. Headquartered in Beihai, China, it underwent a significant rebranding in May 2021, changing its name to better reflect its broadening scope in biological products. The company is not just restricted to manufacturing but also extends its services to medical imaging, tumor therapy, and advanced diagnostic services, showcasing its commendable journey towards becoming a comprehensive healthcare entity in China.

Products and Services

Beihai Gofar Chuanshan Biological Co., Ltd. offers an extensive range of pharmaceutical solutions, from traditional medications to advanced medical services:

  • Pearl Eye Drops: A signature product developed for eye care, emphasizing the traditional use of pearls to improve eye health.
  • Pearl Powder and Nacre Powder: Both are renowned for their health and beauty benefits, used in various skincare and health supplements to promote wellness and vitality.
  • Weiweining Granules: Specially formulated granules aimed at easing digestion and improving gastrointestinal health.
  • Compound Kumu Xiaoyan Tablets: A medical invention geared towards treating inflammation and soreness, showcasing the company's ability to blend traditional knowledge with modern pharmaceutical practices.

Beyond their product line, Beihai Gofar Chuanshan Biological Co., Ltd. also advances in medical services:

  • Molecular Medical Imaging and Tumor Radiotherapy Centers: Facilities equipped with cutting-edge technology for accurate diagnostics and effective cancer treatment.
  • Tumor Telemedicine Technical Services: A modern approach to cancer care, offering patients remote consultations and second opinions from specialists.
  • Molecular Diagnosis and Forensic Identification Technical Services: Providing advanced diagnostic services for a range of medical and legal purposes, utilizing the latest in molecular technology.

Contact Information

Address: No.3 Beibuwan Middle Road, Beihai, China, 536000
Phone: 86 77 9320 0619